ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion.

February 8, 2008

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009

Final Issue of 1980

December 19, 1980

Georgetown Names Cullen Interim Center Director.

November 3, 2000

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006